Furiex Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Furiex Pharmaceuticals

Access the complete profile.

Furiex Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	3900 Paramount Parkway Morrisville, NC 27560

Note: Revenues for privately held companies are statistical evaluations.


Furiex Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Furiex Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Furiex Pharmaceuticals is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Furiex Pharmaceuticals Annual Revenue and Growth Rate

Furiex Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Furiex Pharmaceuticals's revenues are gauged from an analysis of company filings.

Furiex Pharmaceuticals's Income Statement (based on Industry Averages)

Furiex Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Furiex Pharmaceuticals is developing and marketing. Furiex Pharmaceuticals doesn't have any recent trademark applications, indicating Furiex Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
YANTRIA Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases	02/26/2013
XENRYMA Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases	02/21/2013
FURIEX Development, research, testing and consulting services in the field of pharmaceuticals; product development; conducting clinical trials relating to pharmaceuticals	02/11/2010

See all trademarks and details in the Full Report.

Market Share of Furiex Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Furiex Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Furiex Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FURIEX PHARMACEUTICALS	Morrisville, NC	100
RADEAS	Wake Forest, NC	71
BIOFIDELITY	Morrisville, NC	61
ASPIRAR HEALTH	Cary, NC	21
PINE DOG GROUP	Holly Springs, NC	19
GREGORY L RUFF M D P A	Chapel Hill, NC	18

Future Competition: Furiex Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Furiex Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)